MYH14 and COVID-19: Plasma levels of amino acids 3-methylhistidine and 4-hydroxyproline (Fig. 2), originating from actin/myosin and collagen metabolism [18], respectively, were also largely reduced in COVID-19 patients with high IL-6 levels.